News

In the immunopsychiatry research group, we are keen to ensure that our research is easily accessible to the wider public. We are pleased to collaborate with the media to raise awareness of mental illness and mental health research, and to help combat stigma around mental illness. We have participated in filming for TV documentary, and given interviews for TV, radio, print/online news.  In addition to mainstream media, we attend conferences and talks to share our research surrounding mental health and mental illness.

Featured News

Anti-inflammatory drugs might someday treat depression

In the future, a new class of anti-inflammatory drugs could be used to treat depression, say University of Cambridge researchers.


A New Key to Understanding Depression

Scientists are studying alternative explanations for complicated conditions like depression, and researchers from the University of Cambridge are...


Voice of America: Study: Anti-inflammatory Drugs Also Fight Depression

The finding of a new study suggests that anti-inflammatories, as they are known, may take their place alongside conventional treatments to help people with depression.


Protein that fights colds is linked to depression

Children with high levels of a protein that is released in response to coughs, colds and stomach bugs are at greater risk of developing depression and other mental disorders in adulthood, scientists have found.


Kids' responses to infections linked with depression risk

Kids with immune systems that react strongly to infections could have a higher risk of depression, a new study suggests.


Could depression be treated with aspirin or ibuprofen?

Scientists at the University of Cambridge have discovered that inflammation may cause depression, leading to hopes that anti-inflammatory drugs...


Elizabeth Blackwell Institute’s Infection and Immunity Early Career Researchers’ Symposium

Our group members, Daisy and Éimear, presented their latest research at the Infection and Immunity Early Career Researchers’ Symposium held in Bristol on 16 th February 2022.
Daisy’s research focused on investigating the validity of glycoprotein acetyl (GlycA)as an inflammatory biomarker using the ALSPAC cohort. She found evidence of an association between known determinants of inflammation and GlycA and with C-Reactive protein, as well as demonstrating the short and long-term reliability of GlycA. This suggests that GlycA may be a useful measure of chronic inflammation.
Éimear presented her latest research on the peripheral blood cellular immunophenotype in depression. Her findings suggest that depressed patients may have altered counts on a number of blood cells (namely, neutrophils, B cells, and Helper T cells), as compared to healthy comparison groups with no psychiatric history.

Contact Us

We are happy to hear from prospective group members, research collaborators, participants, media, patients and others. Email: info@immunopsychiatry.com

Our address

Medical Research Council Integrative Epidemiology Unit
University of Bristol
Oakfield House
Oakfield Grove
Bristol
BS8 2BN
United Kingdom

   
© Copyright 2024 Golam KhandakerWeb Design By Toolkit Websites